Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA

ANNALS OF ONCOLOGY

ELSEVIER

1. Astra Zeneca
2. Fondation Bergonie
3. LYRICAN [INCA-DGOS-INSERM 12563]
4. LabEx DEvweCAN [ANR-10-LABX-0061]
5. EURACAN [EC 739521]
6. Grant Canope (Ligue contre le Cancer de l'Ain)
7. Ligue contre le Cancer Nationale
8. Fondation ARC